Anastomosis Devices Global Market Report 2024

The anastomosis devices market has grown strongly in recent years. It will grow from $3.49 billion in 2023 to $3.76 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the rise in surgical procedures, an expanding aging population, the prevalence of chronic diseases, enhancements in healthcare infrastructure, and increased awareness and education within the population.

The anastomosis devices market is expected to see strong growth in the next few years. It will grow to $4.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be ascribed to several factors, including the increase in global healthcare expenditure, the expansion of minimally invasive surgeries, advancements in the designs of anastomosis devices, a heightened focus on patient outcomes, and the global upsurge in chronic diseases. Noteworthy trends expected in the forecast period encompass a heightened emphasis on patient outcomes and quality of life, the development of anastomosis sealants, a higher prevalence of colorectal diseases, the global aging population, and an increase in collaborations and partnerships.

The anticipated increase in surgical procedures is expected to drive the anastomosis device market in the future. Surgical procedures encompass any medical intervention involving the incision of a person's body. Anastomosis devices are primarily utilized in surgical procedures to connect two segments of the body, such as blood vessels or intestines. In April 2022, data from 294 plastic surgery practices, as reported by the American Society for Aesthetic Plastic Surgery, revealed a 54% rise in surgical operations and a 44% increase in non-surgical procedures. Additionally, the American Society of Plastic Surgeons noted a 3% growth in reconstructive procedures, with 6.8 million performed in 2022. This surge in surgical procedures is expected to propel the anastomosis device market.

The projected growth of the anastomosis device market is further fueled by the increasing aging population. An aging population denotes a demographic shift marked by a growing proportion of elderly individuals within a society. Anastomosis devices play a vital role in addressing various medical conditions prevalent in the healthcare of the aging population. In October 2022, the World Health Organization forecasted that by 2030, one out of every six individuals globally would be 60 years old or older. The global population of those aged 60 and above is expected to increase from 1 billion in 2020 to 1.4 billion by 2030, and by 2050, it is projected to double to 2.1 billion. Consequently, the rising aging population is a significant driver for the anastomosis device market.

A prominent trend in the anastomosis device market is the introduction of technologically advanced products. Major companies in this market are actively engaged in innovating and launching cutting-edge products and technologies to maintain their market position. A case in point is Intuitive Surgical Inc., a US-based manufacturer of robotic surgical products, which, in June 2021, introduced SureForm, a robot-assisted surgical stapler. SureForm incorporates SmartFire technology, an integrated software that ensures consistent staple lines and prevents damage to patient tissue. The SmartFire technology automatically adjusts the firing process during stapling and transection, optimizing a uniform staple line and minimizing tissue injury across varying tissue thicknesses.

Leading companies in the anastomosis device market are also directing their efforts toward the development of advanced solutions, such as the suture anchor system. This medical device is employed in orthopaedic and sports medicine procedures to securely attach soft tissues (such as tendons or ligaments) to bone. For example, in December 2022, Stryker Corporation, a US-based medical device manufacturing company, launched 'Citrefix,' a suture anchor system designed with innovative bioresorbable material for foot and ankle surgical procedures. Citrefix, a disposable suture system made from Citregen (an elastomeric material derived from a citrate polymer), is engineered to mimic bone chemistry, ensuring controlled resorption without inducing chronic inflammation.

In July 2021, Stille AB, a Sweden-based medical device company, acquired S&T AG for an undisclosed amount. This acquisition is poised to enrich Stille AB's product portfolio and contribute to increased sales, positioning the company as a leader in the premium segment for surgical instruments. S&T AG, based in Switzerland, is recognized for its expertise in manufacturing microsurgical instruments.

Major companies operating in the anastomosis devices market report are Medtronic plc, Synvisc Micro Companies Alliance Inc., B. Braun Melsungen AG, Novare Surgical Systems Inc., Dextera Surgical Inc., Intuitive Surgical Inc., Boston Scientific Corp., Artivion Inc., Johnson & Johnson Services Inc., Röchling Group, Bluesail Surgical, Vascular Graft Solutions Ltd., Baxter International Inc., LivaNova plc, Getinge AB, Meril Life Sciences Pvt. Ltd., Becton, Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Scanlan International Inc., Microline Surgical Inc., Grena Ltd., CryoLife Inc., Cardica Inc., Stryker Corporation, LifeNet Health Inc., Jotec GmbH, JenaValve Technology Inc., Innovia Medical, Genesee BioMedical Inc., EndoEvolution LLC, Edwards Lifesciences Corporation, ConMed Corporation, Cardialen Inc.

North America was the largest region in the anastomosis devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global anastomosis devices market report during the forecast period. The regions covered in the anastomosis devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anastomosis devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of anastomosis devices include surgical staplers, surgical sutures, surgical sealants and adhesives, and automated suturing. Surgical staplers are tools employed to close significant surgical wounds or incisions on the scalp or skin, applying staples to various tissues within the body during surgery. They find application in cardiovascular and thoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, and other medical procedures. These devices are utilized in various healthcare settings such as hospitals and ambulatory surgery centers, among others.

The anastomosis devices market research report provides anastomosis devices market statistics, including the anastomosis devices industry global market size, regional shares, competitors with an anastomosis devices market share, detailed anastomosis devices market segments, market trends, and opportunities, and any further data you may need to thrive in the anastomosis devices industry. This anastomosis devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anastomosis devices market consists of sales of cannula, robotics, and incision devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.